Brief: Beam Therapeutics Q2 net income USD -82.776 million
08/08/2023 11:40
Aug 8 (Reuters) - Beam Therapeutics Q2 net income USD -82.776 million. * Q2 operating income USD -102.148 million * Q2 operating expenses USD 122.264 million
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta